Thermo Fisher Scientific Human IFN-alpha 2 (alpha 2b) (Carrier-Free) Recombinant Protein
인간 IFN-alpha 2b 재조합 단백질로 항바이러스 및 면역조절 기능을 연구용으로 활용 가능. E. coli 발현 시스템에서 생산되며 ≥95% 순도. Carrier-free 액상 형태로 제공, -80°C 보관. 세포 기반 기능적 분석 및 ELISA 등 다양한 어세이에 적합.
- 카탈로그번호
- PHC4064
- 카테고리
- Protein
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Human IFN-alpha 2 (alpha 2b) (Carrier-Free) Recombinant Protein
Applications
Western Blot (WB)
- Assay-dependent
Immunohistochemistry (IHC)
- Assay-dependent
ELISA
- Assay-dependent
Functional Assay
- Assay-dependent
Control
- Assay-dependent
Product Specifications
| 항목 | 내용 |
|---|---|
| Species | Human |
| Expression System | E. coli |
| Molecular Weight | 19.2 kDa |
| Class | Recombinant |
| Type | Protein |
| Purity | ≥95% by SDS-PAGE |
| Activity | Specific Activity = 2.38×10⁸ units/mg; measured by cytopathic effect inhibition assay (Rubinstein et al., 1981; Familletti et al., 1981). Determined using bovine MDBK cells challenged with vesicular stomatitis virus (VSV). |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification | Purified |
| Contains | No preservative |
| Storage Conditions | -80°C |
| Shipping Conditions | Dry ice |
Product Specific Information
- Carrier-Free
- Dilution Recommendation: Further dilutions should be made in medium or buffered solution containing carrier protein such as PBS with 0.1% BSA.
- Storage: Store human IFN-Alpha 2 at -70°C. Upon initial thawing, apportion contents into working aliquots and store at -70°C. Avoid repeated freeze-thaw cycles.
Target Information
Interferon alpha-2b is a cytokine belonging to the type I interferon family, encoded by a gene cluster on chromosome 9. It is produced in response to viral infection and plays a key role in the innate immune response, exhibiting potent antiviral, antiproliferative, and immunomodulatory properties.
This cytokine binds to the plasma membrane receptor complex IFNAR1/IFNAR2, expressed ubiquitously across tissues, enabling broad cellular activity. It has demonstrated efficacy in reducing symptoms and duration of the common cold and in treating various cancers, including hematologic malignancies and solid tumors.
Deficiency of type I interferon is considered a hallmark of severe COVID-19, and interferon alpha-2b combination therapy may be a potential therapeutic approach. IFNA2 has been associated with diseases such as Severe COVID-19 and Hepatitis B.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.